Release Date: May 14, 2025
Expiration Date: May 14, 2026
Activity Overview
Modern glaucoma management incorporates a wide variety of therapies, with more options becoming available recently. This educational program offers expert perspectives on individualizing glaucoma therapy with topical medications, selective laser trabeculoplasty, sustained-release drug implants, and micro-invasive glaucoma surgery procedures, providing key take-home insights for optimizing glaucoma management across diverse patient profiles.
This educational activity is an archive of the live virtual symposium held on March 30, 2025.
Target Audience
This educational activity is directed toward optometrists, ophthalmologists, and other eyecare professionals involved in the management of patients with glaucoma.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the role of the conventional (trabecular) pathway for aqueous outflow in the development of ocular hypertension and open-angle glaucoma
- Evaluate the mechanisms of traditional and novel topical agents for intraocular pressure lowering, including their aqueous outflow targets
- Assess nontopical therapies available for management of ocular hypertension and open-angle glaucoma, including laser procedures and sustained drug delivery options
- Implement the latest advances in minimally invasive glaucoma surgery in appropriate patients
Deborah Ristvedt, DO
Anterior Segment Surgeon
Vance Thompson Vision
Alexandria, MN
Disclosures: Consultant: AbbVie, BVI Medical, Glaukos, Johnson & Johnson Surgical Vision, RxSight, Sight Sciences; Speakers Bureau: AbbVie, BVI Medical, Glaukos, Johnson & Johnson Surgical Vision, RxSight, Sight Sciences.
Melissa Tawa, OD, FAAO
Assistant Professor
Southern California College of Optometry
Marshall B. Ketchum University
Anaheim, CA
Disclosures: Melissa Tawa, OD, FAAO, has no relevant financial relationships with ineligible companies.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource, LLC (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
